Clinical Trial Update: To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating NYC 0462 ointment for plaque psoriasis has been withdrawn. Sponsor Fougera Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• NYC 0462 Ointment

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: WITHDRAWN